Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
FerroAtlántica
GSM
$818M
| $2.25M | ﹤0.01% |
612,015
-536,482
| -47% | -$1.97M |
|
2727
Castle Biosciences
CSTL
$960M
| $2.24M | ﹤0.01% |
109,743
+66,928
| +156% | +$1.24M |
|
2728
Cellebrite
CLBT
$2.69B
| $2.24M | ﹤0.01% |
140,037
-13,987
| -9% | -$249K |
|
|
EFC
2729
Ellington Financial
EFC
$1.76B
| $2.24M | ﹤0.01% |
172,413
+61,212
| +55% | +$778K |
|
|
ORLA
2730
DELISTED
Orla Mining
ORLA
| $2.24M | ﹤0.01% |
223,284
-29,070
| -12% | -$302K |
|
2731
Clover Health Investments
CLOV
$2.41B
| $2.23M | ﹤0.01% |
800,674
+354,520
| +79% | +$1.17M |
|
2732
CALL
Coherent
COHR
$64B
| $2.23M | ﹤0.01% |
+25,000
| New | +$1.8M |
|
|
SEI
2733
Solaris Energy Infrastructure
SEI
$4.07B
| $2.22M | ﹤0.01% |
78,620
+3,943
| +5% | +$92.8K |
|
2734
Intuitive Machines
LUNR
$2.82B
| $2.22M | ﹤0.01% |
204,282
+118,233
| +137% | +$1.16M |
|
2735
Janus International
JBI
$664M
| $2.22M | ﹤0.01% |
272,780
+85,271
| +45% | +$650K |
|
2736
AnaptysBio
ANAB
$1.66B
| $2.22M | ﹤0.01% |
99,999
+43,780
| +78% | +$916K |
|
2737
Astec Industries
ASTE
$994M
| $2.22M | ﹤0.01% |
53,198
+14,066
| +36% | +$534K |
|
2738
ImmunityBio
IBRX
$8.2B
| $2.22M | ﹤0.01% |
839,894
+474,859
| +130% | +$1.28M |
|
2739
Under Armour
UAA
$2.3B
| $2.21M | ﹤0.01% |
323,748
-769,782
| -70% | -$4.79M |
|
2740
BJ's Restaurants
BJRI
$1.48B
| $2.21M | ﹤0.01% |
49,499
+18,922
| +62% | +$747K |
|
2741
CALL
CleanSpark
CLSK
$2.96B
| $2.21M | ﹤0.01% |
+200,000
| New | +$1.78M |
|
2742
Radware
RDWR
$1.22B
| $2.2M | ﹤0.01% |
74,733
-834
| -1% | -$19.7K |
|
2743
Safety Insurance
SAFT
$1.52B
| $2.2M | ﹤0.01% |
27,707
+9,104
| +49% | +$719K |
|
2744
PUT
Sable Offshore Corp
SOC
$773M
| $2.2M | ﹤0.01% |
+100,000
| New | +$2.33M |
|
|
APO.PRA
2745
DELISTED
Apollo Global Management Series A
APO.PRA
| $2.2M | ﹤0.01% |
29,337
-47,329
| -62% | -$3.35M |
|
2746
Helios Technologies
HLIO
$2.66B
| $2.19M | ﹤0.01% |
65,685
+20,382
| +45% | +$614K |
|
2747
Vanguard Russell 2000 ETF
VTWO
$17.5B
| $2.19M | ﹤0.01% |
+25,113
| New | +$2.04M |
|
2748
Employers Holdings
EIG
$864M
| $2.19M | ﹤0.01% |
46,321
+14,059
| +44% | +$678K |
|
2749
Amplitude
AMPL
$1.55B
| $2.18M | ﹤0.01% |
176,084
+72,625
| +70% | +$786K |
|
|
PGRE
2750
DELISTED
Paramount Group
PGRE
| $2.18M | ﹤0.01% |
356,586
-28,070
| -7% | -$146K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.